Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.

Identifieur interne : 003759 ( PubMed/Checkpoint ); précédent : 003758; suivant : 003760

The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.

Auteurs : Fred B. Berry [Canada] ; Yahya Tamimi ; Michelle V. Carle ; Ordan J. Lehmann ; Michael A. Walter

Source :

RBID : pubmed:16081467

Descripteurs français

English descriptors

Abstract

The FOX family of transcription factor genes is an evolutionary conserved, yet functionally diverse class of transcription factors that are important for regulation of energy homeostasis, development and oncogenesis. The proteins encoded by FOX genes are characterized by a conserved DNA-binding domain known as the forkhead domain (FHD). To date, disease-causing mutations have been identified in eight human FOX genes. Many of these mutations result in single amino acid substitutions in the FHD. We analyzed the molecular consequences of two disease-causing missense mutations (R121H and S125L) occurring in the FHD of the FOXC2 gene that were identified in patients with hereditary lymphedema with distichiasis (LD) to test the predictive capacity of a FHD structure/function model. On the basis of the FOXC2 solution structure, both FOXC2 missense mutations are located on the DNA-recognition helix of the FHD. A mutation model based on the parologous FOXC1 protein predicts that these FOXC2 missense mutations will impair the DNA-binding and transcriptional activation ability of the FOXC2 protein. When these mutations were analyzed biochemically, we found that both mutations did indeed reduce the DNA binding and transcriptional capacity. In addition, the R121H mutation affected nuclear localization of FOXC2. Together, these data indicate that these FOXC2 missense mutations are functional nulls and that FOXC2 haploinsufficiency underlies hereditary LD and validates the predictive ability of the FOXC1-based FHD mutational model.

DOI: 10.1093/hmg/ddi295
PubMed: 16081467


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:16081467

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.</title>
<author>
<name sortKey="Berry, Fred B" sort="Berry, Fred B" uniqKey="Berry F" first="Fred B" last="Berry">Fred B. Berry</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. fberry@ualberta.ca</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Ophthalmology, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tamimi, Yahya" sort="Tamimi, Yahya" uniqKey="Tamimi Y" first="Yahya" last="Tamimi">Yahya Tamimi</name>
</author>
<author>
<name sortKey="Carle, Michelle V" sort="Carle, Michelle V" uniqKey="Carle M" first="Michelle V" last="Carle">Michelle V. Carle</name>
</author>
<author>
<name sortKey="Lehmann, Ordan J" sort="Lehmann, Ordan J" uniqKey="Lehmann O" first="Ordan J" last="Lehmann">Ordan J. Lehmann</name>
</author>
<author>
<name sortKey="Walter, Michael A" sort="Walter, Michael A" uniqKey="Walter M" first="Michael A" last="Walter">Michael A. Walter</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16081467</idno>
<idno type="pmid">16081467</idno>
<idno type="doi">10.1093/hmg/ddi295</idno>
<idno type="wicri:Area/PubMed/Corpus">003C28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C28</idno>
<idno type="wicri:Area/PubMed/Curation">003C28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C28</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003C28</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003C28</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.</title>
<author>
<name sortKey="Berry, Fred B" sort="Berry, Fred B" uniqKey="Berry F" first="Fred B" last="Berry">Fred B. Berry</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. fberry@ualberta.ca</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Ophthalmology, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tamimi, Yahya" sort="Tamimi, Yahya" uniqKey="Tamimi Y" first="Yahya" last="Tamimi">Yahya Tamimi</name>
</author>
<author>
<name sortKey="Carle, Michelle V" sort="Carle, Michelle V" uniqKey="Carle M" first="Michelle V" last="Carle">Michelle V. Carle</name>
</author>
<author>
<name sortKey="Lehmann, Ordan J" sort="Lehmann, Ordan J" uniqKey="Lehmann O" first="Ordan J" last="Lehmann">Ordan J. Lehmann</name>
</author>
<author>
<name sortKey="Walter, Michael A" sort="Walter, Michael A" uniqKey="Walter M" first="Michael A" last="Walter">Michael A. Walter</name>
</author>
</analytic>
<series>
<title level="j">Human molecular genetics</title>
<idno type="ISSN">0964-6906</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>DNA Primers</term>
<term>Electrophoretic Mobility Shift Assay</term>
<term>Eyelashes (abnormalities)</term>
<term>Fluorescent Antibody Technique</term>
<term>Forkhead Transcription Factors (genetics)</term>
<term>Humans</term>
<term>Luciferases</term>
<term>Lymphedema (complications)</term>
<term>Lymphedema (genetics)</term>
<term>Models, Genetic</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Mutagenesis, Site-Directed</term>
<term>Mutation, Missense (genetics)</term>
<term>Sequence Analysis, DNA</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Amorces ADN</term>
<term>Analyse de séquence d'ADN</term>
<term>Cils (malformations)</term>
<term>Données de séquences moléculaires</term>
<term>Facteurs de transcription Forkhead (génétique)</term>
<term>Humains</term>
<term>Luciferases</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (génétique)</term>
<term>Modèles génétiques</term>
<term>Modèles moléculaires</term>
<term>Mutagenèse dirigée</term>
<term>Mutation faux-sens (génétique)</term>
<term>Séquence d'acides aminés</term>
<term>Technique d'immunofluorescence</term>
<term>Test de retard de migration électrophorétique</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Forkhead Transcription Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>DNA Primers</term>
<term>Luciferases</term>
</keywords>
<keywords scheme="MESH" qualifier="abnormalities" xml:lang="en">
<term>Eyelashes</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Lymphedema</term>
<term>Mutation, Missense</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Facteurs de transcription Forkhead</term>
<term>Lymphoedème</term>
<term>Mutation faux-sens</term>
</keywords>
<keywords scheme="MESH" qualifier="malformations" xml:lang="fr">
<term>Cils</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Electrophoretic Mobility Shift Assay</term>
<term>Fluorescent Antibody Technique</term>
<term>Humans</term>
<term>Models, Genetic</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Mutagenesis, Site-Directed</term>
<term>Sequence Analysis, DNA</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Amorces ADN</term>
<term>Analyse de séquence d'ADN</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Luciferases</term>
<term>Lymphoedème</term>
<term>Modèles génétiques</term>
<term>Modèles moléculaires</term>
<term>Mutagenèse dirigée</term>
<term>Séquence d'acides aminés</term>
<term>Technique d'immunofluorescence</term>
<term>Test de retard de migration électrophorétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The FOX family of transcription factor genes is an evolutionary conserved, yet functionally diverse class of transcription factors that are important for regulation of energy homeostasis, development and oncogenesis. The proteins encoded by FOX genes are characterized by a conserved DNA-binding domain known as the forkhead domain (FHD). To date, disease-causing mutations have been identified in eight human FOX genes. Many of these mutations result in single amino acid substitutions in the FHD. We analyzed the molecular consequences of two disease-causing missense mutations (R121H and S125L) occurring in the FHD of the FOXC2 gene that were identified in patients with hereditary lymphedema with distichiasis (LD) to test the predictive capacity of a FHD structure/function model. On the basis of the FOXC2 solution structure, both FOXC2 missense mutations are located on the DNA-recognition helix of the FHD. A mutation model based on the parologous FOXC1 protein predicts that these FOXC2 missense mutations will impair the DNA-binding and transcriptional activation ability of the FOXC2 protein. When these mutations were analyzed biochemically, we found that both mutations did indeed reduce the DNA binding and transcriptional capacity. In addition, the R121H mutation affected nuclear localization of FOXC2. Together, these data indicate that these FOXC2 missense mutations are functional nulls and that FOXC2 haploinsufficiency underlies hereditary LD and validates the predictive ability of the FOXC1-based FHD mutational model.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">16081467</PMID>
<DateCreated>
<Year>2005</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2006</Year>
<Month>02</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0964-6906</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>14</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2005</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Human molecular genetics</Title>
<ISOAbbreviation>Hum. Mol. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.</ArticleTitle>
<Pagination>
<MedlinePgn>2619-27</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The FOX family of transcription factor genes is an evolutionary conserved, yet functionally diverse class of transcription factors that are important for regulation of energy homeostasis, development and oncogenesis. The proteins encoded by FOX genes are characterized by a conserved DNA-binding domain known as the forkhead domain (FHD). To date, disease-causing mutations have been identified in eight human FOX genes. Many of these mutations result in single amino acid substitutions in the FHD. We analyzed the molecular consequences of two disease-causing missense mutations (R121H and S125L) occurring in the FHD of the FOXC2 gene that were identified in patients with hereditary lymphedema with distichiasis (LD) to test the predictive capacity of a FHD structure/function model. On the basis of the FOXC2 solution structure, both FOXC2 missense mutations are located on the DNA-recognition helix of the FHD. A mutation model based on the parologous FOXC1 protein predicts that these FOXC2 missense mutations will impair the DNA-binding and transcriptional activation ability of the FOXC2 protein. When these mutations were analyzed biochemically, we found that both mutations did indeed reduce the DNA binding and transcriptional capacity. In addition, the R121H mutation affected nuclear localization of FOXC2. Together, these data indicate that these FOXC2 missense mutations are functional nulls and that FOXC2 haploinsufficiency underlies hereditary LD and validates the predictive ability of the FOXC1-based FHD mutational model.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Berry</LastName>
<ForeName>Fred B</ForeName>
<Initials>FB</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. fberry@ualberta.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tamimi</LastName>
<ForeName>Yahya</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carle</LastName>
<ForeName>Michelle V</ForeName>
<Initials>MV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lehmann</LastName>
<ForeName>Ordan J</ForeName>
<Initials>OJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Walter</LastName>
<ForeName>Michael A</ForeName>
<Initials>MA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2005</Year>
<Month>08</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Hum Mol Genet</MedlineTA>
<NlmUniqueID>9208958</NlmUniqueID>
<ISSNLinking>0964-6906</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C082078">mesenchyme fork head 1 protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.13.12.-</RegistryNumber>
<NameOfSubstance UI="D008156">Luciferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D024202" MajorTopicYN="N">Electrophoretic Mobility Shift Assay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005140" MajorTopicYN="N">Eyelashes</DescriptorName>
<QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008958" MajorTopicYN="Y">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2005</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2005</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">16081467</ArticleId>
<ArticleId IdType="pii">ddi295</ArticleId>
<ArticleId IdType="doi">10.1093/hmg/ddi295</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Carle, Michelle V" sort="Carle, Michelle V" uniqKey="Carle M" first="Michelle V" last="Carle">Michelle V. Carle</name>
<name sortKey="Lehmann, Ordan J" sort="Lehmann, Ordan J" uniqKey="Lehmann O" first="Ordan J" last="Lehmann">Ordan J. Lehmann</name>
<name sortKey="Tamimi, Yahya" sort="Tamimi, Yahya" uniqKey="Tamimi Y" first="Yahya" last="Tamimi">Yahya Tamimi</name>
<name sortKey="Walter, Michael A" sort="Walter, Michael A" uniqKey="Walter M" first="Michael A" last="Walter">Michael A. Walter</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Berry, Fred B" sort="Berry, Fred B" uniqKey="Berry F" first="Fred B" last="Berry">Fred B. Berry</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003759 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003759 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:16081467
   |texte=   The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:16081467" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024